Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ascendis Pharma A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ASND
Nasdaq
2836
ascendispharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ascendis Pharma A/S
New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
- May 12th, 2025 8:45 pm
Launch of New Drug Lifted Ascendis Pharma A/S (ASND) in Q1
- May 6th, 2025 12:08 pm
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
- May 5th, 2025 12:30 pm
Ascendis Pharma A/S (NASDAQ:ASND) Just Released Its First-Quarter Earnings: Here's What Analysts Think
- May 4th, 2025 1:08 pm
Ascendis Pharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
- May 3rd, 2025 12:52 pm
Ascendis Pharma AS (ASND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...
- May 2nd, 2025 7:17 am
Ascendis Pharma Reports First Quarter 2025 Financial Results
- May 1st, 2025 8:01 pm
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
- Apr 24th, 2025 8:01 pm
Reddit initiated, Target downgraded: Wall Street’s top analyst calls
- Apr 17th, 2025 3:00 pm
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
- Apr 16th, 2025 1:40 pm
Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires?
- Apr 14th, 2025 6:03 pm
High Growth Tech Stocks In US With Potential For Expansion
- Apr 14th, 2025 5:38 pm
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
- Mar 31st, 2025 8:01 pm
Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?
- Mar 18th, 2025 1:49 pm
Exploring US High Growth Tech Stocks In March 2025
- Mar 3rd, 2025 5:08 pm
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
- Feb 24th, 2025 9:01 pm
Ascendis Pharma A/S (NASDAQ:ASND) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
- Feb 15th, 2025 12:38 pm
Ascendis Pharma Full Year 2024 Earnings: Beats Expectations
- Feb 14th, 2025 10:59 am
Ascendis Pharma AS (ASND) Q4 2024 Earnings Call Highlights: Strategic Growth and Market ...
- Feb 14th, 2025 5:00 am
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
- Feb 13th, 2025 7:40 pm
Scroll